Everyone Deserves To Be Well
At Atlantic Research Group, we know how difficult it is to develop a drug. But, we also know that great things happen when passionate people combine their strengths. Together, we create smart, feasible studies with protocols that reflect everyday life. We connect individuals — even if there are only 50 in the entire world with a particularly rare disease — to organizations that have the drive and know-how to develop potential treatments. We uncover far-reaching insights in drug research, no matter how limited data may be. Let’s unite and finish the journey from trial to treatment.
We are excited to let you know that ARG CEO Paul Bishop and Senior Vice-President of Business Development Mike Baker will be attending the JP Morgan Healthcare Conference in San Francisco on January 13-15, 2020.
ARG has made its reputation working with emerging organizations by leveraging our experience in complex clinical trial management. We have achieved our track record by combining individualized customer service with leading technology solutions.
We specialize in the needs of agile and emerging biopharmaceutical companies
Start with one savvy business leader with a passion for execution, and another with passion for therapeutic technologies and the process of bringing them to market. Add an accomplished professor from one of the world’s most prestigious universities. These are the fundamental ingredients of Atlantic Research Group.